Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
出版年份 2020 全文链接
标题
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
作者
关键词
-
出版物
EPMA Journal
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-15
DOI
10.1007/s13167-020-00203-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Modulation of the Endocannabinoid System Following Central Nervous System Injury
- (2019) Juan Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies
- (2019) Tarek Taha et al. ONCOLOGIST
- Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach
- (2019) Jiri Polivka et al. EPMA Journal
- Vaginal dryness: individualised patient profiles, risks and mitigating measures
- (2019) Vadym Goncharenko et al. EPMA Journal
- La plasticidad sináptica mediada por endocannabinoides y «trastornos por consumo de drogas»
- (2019) E. Fernández-Espejo et al. NEUROLOGIA
- Challenges to curing primary brain tumours
- (2019) Kenneth Aldape et al. Nature Reviews Clinical Oncology
- Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
- (2019) Eva Martínez-Pinilla et al. MOLECULAR NEUROBIOLOGY
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- Cannabinoid receptor as a potential therapeutic target for Parkinson’s Disease
- (2019) Himadri Shekhaar Baul et al. BRAIN RESEARCH BULLETIN
- Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189
- (2019) Natalie M. Guley et al. EXPERIMENTAL EYE RESEARCH
- Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
- (2019) Marina Peball et al. JOURNAL OF NEURAL TRANSMISSION
- Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Anoop P Patel et al. LANCET NEUROLOGY
- Hippocampal Stratum Oriens Somatostatin-Positive Cells Undergo CB1-Dependent Long-Term Potentiation and Express Endocannabinoid Biosynthetic Enzymes
- (2019) Lindsey Friend et al. MOLECULES
- Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease
- (2019) Jenny Ceccarini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cell type specific impact of cannabinoid receptor signaling in somatosensory barrel map formation in mice
- (2019) Jana Hedrich et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease
- (2019) Sonia Burgaz et al. MOLECULES
- Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis
- (2019) Jing Wang et al. Biomed Research International
- Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the Literature
- (2019) RUDOLF LIKAR et al. ANTICANCER RESEARCH
- Cannabis in the treatment of traumatic brain injury: A primer for clinicians
- (2019) Karl Grenier et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Cannabis and Cannabinoid Biology in Stroke
- (2019) Sang-Ho Choi et al. STROKE
- Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
- (2019) Zinah Zamil Al-Ghezi et al. Frontiers in Immunology
- Flammer syndrome in multiple sclerosis: diagnostics, prediction, and personalization of treatments
- (2019) Cihat Uzunköprü et al. EPMA Journal
- Cannabis, alcohol and cigarette use during the acute post-concussion period
- (2019) David W. Lawrence et al. BRAIN INJURY
- Antinociceptive effects of treadmill exercise in a rat model of Parkinson's disease: The role of cannabinoid and opioid receptors
- (2019) K.H. Binda et al. BRAIN RESEARCH
- Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial
- (2019) Berzenn Urbi et al. BMJ Open
- Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data
- (2019) Thorsten Rudroff Frontiers in Pharmacology
- Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials
- (2019) Sinje Gehr et al. EPMA Journal
- Amelioration of visual deficits and visual system pathology after mild TBI via the cannabinoid Type-2 receptor inverse agonism of raloxifene
- (2019) Marcia G. Honig et al. EXPERIMENTAL NEUROLOGY
- Cannabinoids and the expanded endocannabinoid system in neurological disorders
- (2019) Luigia Cristino et al. Nature Reviews Neurology
- Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease
- (2019) Glauce Crivelaro do Nascimento et al. NEUROPHARMACOLOGY
- The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
- (2019) Qi-Wen Han et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System
- (2018) Shana M. Augustin et al. ACS Chemical Neuroscience
- Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats
- (2018) Jennifer A. Shearer et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cannabis Use in Individuals With Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado
- (2018) Lenore A. Hawley et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization
- (2018) Molly Braun et al. BRAIN BEHAVIOR AND IMMUNITY
- Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB 1 and CB 2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
- (2018) Gemma Navarro et al. BRAIN BEHAVIOR AND IMMUNITY
- The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
- (2018) Suzanne Nielsen et al. Current Neurology and Neuroscience Reports
- Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
- (2018) Talarico Giuseppina et al. Current Neuropharmacology
- Biphasic effects of THC in memory and cognition
- (2018) Edward J. Calabrese et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cannabis sativa (Marijuana) alters blood chemistry and the cytoarchitecture of some organs in Sprague Dawley rat models
- (2018) Nosarieme Omoregie Abey FOOD AND CHEMICAL TOXICOLOGY
- Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer’s Disease-Like Pathology
- (2018) Anne-Caroline Schmöle et al. JOURNAL OF ALZHEIMERS DISEASE
- A TLR/AKT/FoxO3 immune tolerance–like pathway disrupts the repair capacity of oligodendrocyte progenitors
- (2018) Taasin Srivastava et al. JOURNAL OF CLINICAL INVESTIGATION
- Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor
- (2018) Concepción García et al. Journal of Neuroinflammation
- Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol
- (2018) Yosef Sarne et al. NEUROBIOLOGY OF AGING
- [ 18 F]FMPEP- d 2 PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer's disease
- (2018) Jatta S. Takkinen et al. NEUROBIOLOGY OF AGING
- Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson’s Disease
- (2018) Francisco Navarrete et al. Neurotherapeutics
- Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer’s disease-like mice overexpressing the human mutant amyloid precursor protein
- (2018) Mauro Maccarrone et al. PHARMACOLOGICAL RESEARCH
- The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
- (2018) Valerio Chiurchiù et al. PROGRESS IN NEUROBIOLOGY
- Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression
- (2018) Wei Xiang et al. Nature Communications
- Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
- (2018) Claudia A. Dumitru et al. Frontiers in Molecular Neuroscience
- Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine
- (2018) Olga Golubnitschaja et al. EPMA Journal
- Preventive, predictive, and personalized medicine for effective and affordable cancer care
- (2018) Jaak Ph. Janssens et al. EPMA Journal
- The crucial role of multiomic approach in cancer research and clinically relevant outcomes
- (2018) Miaolong Lu et al. EPMA Journal
- Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma
- (2018) Israel López-Valero et al. BIOCHEMICAL PHARMACOLOGY
- The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease
- (2018) Gaurav Bedse et al. JOURNAL OF ALZHEIMERS DISEASE
- Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression
- (2018) Iván Manuel et al. JOURNAL OF ALZHEIMERS DISEASE
- Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model
- (2018) Mustafa Nazıroğlu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity
- (2018) Libat Weizman et al. NEUROLOGY
- Medical Use of Cannabinoids
- (2018) Ana Isabel Fraguas-Sánchez et al. DRUGS
- Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
- (2018) Aida Habib et al. GUT
- Therapeutic effect of a novel fatty acid amide hydrolase inhibitor PF04457845 in the repetitive closed head injury mouse model
- (2018) Prabhuanand Selvaraj et al. JOURNAL OF NEUROTRAUMA
- Global Burden of Neurological Disorders: From Global Burden of Disease Estimates to Actions
- (2018) Valery L. Feigin et al. NEUROEPIDEMIOLOGY
- The Endocannabinoid System and Oligodendrocytes in Health and Disease
- (2018) Alexander A. Ilyasov et al. Frontiers in Neuroscience
- Predictive and individualized management of stroke—success story in Czech Republic
- (2018) Jiri Polivka et al. EPMA Journal
- Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease
- (2018) Marco Gentili et al. PHARMACOLOGICAL RESEARCH
- Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model
- (2018) Erika Simmerman et al. JOURNAL OF SURGICAL RESEARCH
- Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet
- (2017) Gaetano Terrone et al. EPILEPSIA
- Strokes are possible complications of cannabinoids use
- (2017) Valérie Wolff et al. EPILEPSY & BEHAVIOR
- Role of cannabis in digestive disorders
- (2017) Hemant Goyal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- An update on the advancements in the treatment of agitation in Alzheimer’s disease
- (2017) Anton P. Porsteinsson et al. EXPERT OPINION ON PHARMACOTHERAPY
- Emotion regulation deficits in regular marijuana users
- (2017) Kaeli Zimmermann et al. HUMAN BRAIN MAPPING
- (−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis
- (2017) Thaís Alberti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of Myeloid TLR4 Mediates T Lymphocyte Polarization after Traumatic Brain Injury
- (2017) Molly Braun et al. JOURNAL OF IMMUNOLOGY
- Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis
- (2017) Pasquale Annunziata et al. JOURNAL OF NEUROIMMUNOLOGY
- Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability
- (2017) Jacques Mayeux et al. JOURNAL OF NEUROTRAUMA
- Operative Treatment of 2-Part Surgical Neck Fracture of the Humerus
- (2017) Wonyong Lee et al. JOURNAL OF ORTHOPAEDIC TRAUMA
- Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer’s Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway
- (2017) Lin Wang et al. MOLECULAR NEUROBIOLOGY
- Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors
- (2017) Jian Zhang et al. MOLECULAR NEUROBIOLOGY
- A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice
- (2017) Andras Bilkei-Gorzo et al. NATURE MEDICINE
- The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy
- (2017) Paula Province Warren et al. NEUROCASE
- Efecto del inhibidor de amida hidrolasa de ácidos grasos en el daño neuronal dopaminérgico inducido por MPTP
- (2017) J.M. Viveros-Paredes et al. NEUROLOGIA
- Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke
- (2017) Maria Ceprián et al. NEUROPHARMACOLOGY
- Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy
- (2017) Anna-Maria Szczesniak et al. NEUROPHARMACOLOGY
- The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity
- (2017) Roberto Colangeli et al. Scientific Reports
- Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
- (2017) Tommaso Cassano et al. Frontiers in Neuroscience
- A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
- (2017) Salahaden R. Sultan et al. Frontiers in Pharmacology
- Endocannabinoids: A Promising Impact for Traumatic Brain Injury
- (2017) Lesley D. Schurman et al. Frontiers in Pharmacology
- Role of cannabis in cardiovascular disorders
- (2017) Hemant Goyal et al. Journal of Thoracic Disease
- Cannabis and Multiple Sclerosis—The Way Forward
- (2017) Thorsten Rudroff et al. Frontiers in Neurology
- Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry
- (2017) Azmeraw T. Amare et al. EPMA Journal
- Targeting the Endocannabinoid System in Alzheimer's Disease
- (2017) Jeremy Koppel et al. JOURNAL OF ALZHEIMERS DISEASE
- Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
- (2016) Sonia Hernández-Tiedra et al. Autophagy
- Absence of gut microbiota influences lipopolysaccharide-induced behavioral changes in mice
- (2016) Alline C. Campos et al. BEHAVIOURAL BRAIN RESEARCH
- An Introduction to the Endogenous Cannabinoid System
- (2016) Hui-Chen Lu et al. BIOLOGICAL PSYCHIATRY
- Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson’s disease
- (2016) Marta Celorrio et al. BRAIN BEHAVIOR AND IMMUNITY
- Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors
- (2016) William H Hind et al. BRITISH JOURNAL OF PHARMACOLOGY
- Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease
- (2016) Rawaha Ahmad et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury
- (2016) Ana Belen Lopez-Rodriguez et al. EXPERIMENTAL NEUROLOGY
- Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease
- (2016) Ruth M. Concannon et al. EXPERIMENTAL NEUROLOGY
- Cannabinoids, inflammation, and fibrosis
- (2016) Robert B. Zurier et al. FASEB JOURNAL
- Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
- (2016) Assaf Shelef et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine
- (2016) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- Prognostic factors in C9orf72 amyotrophic lateral sclerosis
- (2016) José Manuel Matamala et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease
- (2016) Shreesh Ojha et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
- (2016) A. Vanessa Stempel et al. NEURON
- Stimulation of brain glucose uptake by cannabinoid CB 2 receptors and its therapeutic potential in Alzheimer's disease
- (2016) Attila Köfalvi et al. NEUROPHARMACOLOGY
- Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons
- (2016) Önder Albayram et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease
- (2016) Shalini Jayant et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
- (2016) F.F. Peres et al. SCHIZOPHRENIA RESEARCH
- Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke
- (2016) Isabel Bravo-Ferrer et al. STROKE
- Association of anandamide with altered binocular depth inversion illusion in schizophrenia
- (2016) Anne R. Reuter et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis
- (2016) Marie-Louise Zeissler et al. Oncotarget
- VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
- (2016) Javier Díaz-Alonso et al. Scientific Reports
- CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
- (2016) Ester Aso et al. Frontiers in Neuroscience
- Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting
- (2016) Erin M. Rock et al. Frontiers in Pharmacology
- Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016
- (2016) Olga Golubnitschaja et al. EPMA Journal
- Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson’s Disease
- (2016) Yilin Tang et al. PLoS One
- Salvia miltiorrhiza extract protects white matter and the hippocampus from damage induced by chronic cerebral hypoperfusion in rats
- (2015) Min-Soo Kim et al. BMC Complementary and Alternative Medicine
- Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling
- (2015) Ki Mo Lee et al. BMC Complementary and Alternative Medicine
- Endocannabinoids modulate human blood-brain barrier permeabilityin vitro
- (2015) William H Hind et al. BRITISH JOURNAL OF PHARMACOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation
- (2015) J.T. Toguri et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
- (2015) Celina S. Liu et al. CNS DRUGS
- Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease
- (2015) Ruth M. Concannon et al. EXPERIMENTAL NEUROLOGY
- Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease
- (2015) Francesco Panza et al. EXPERT OPINION ON PHARMACOTHERAPY
- The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
- (2015) Demetrios Moris et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis
- (2015) Sven G Meuth et al. Expert Review of Neurotherapeutics
- Medical Marijuana
- (2015) Amy E. Thompson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Medical Use of Cannabinoids
- (2015) Igor Grant JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Medical Use of Cannabinoids
- (2015) Michael E. Schatman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inhibition of Monoacylglycerol Lipase Prevents Chronic Traumatic Encephalopathy-like Neuropathology in a Mouse Model of Repetitive Mild Closed Head Injury
- (2015) Jian Zhang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Cannabinoids in Experimental Stroke: A Systematic Review and Meta-Analysis
- (2015) Timothy J England et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Endocannabinoid Degradation Inhibition Improves Neurobehavioral Function, Blood–Brain Barrier Integrity, and Neuroinflammation following Mild Traumatic Brain Injury
- (2015) Paige S. Katz et al. JOURNAL OF NEUROTRAUMA
- The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
- (2015) Jan van Amsterdam et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Endocannabinoid signalling and the deteriorating brain
- (2015) Vincenzo Di Marzo et al. NATURE REVIEWS NEUROSCIENCE
- Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice
- (2015) E.L. von Rüden et al. NEUROBIOLOGY OF DISEASE
- Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats
- (2015) A.A. Martinez et al. NEUROBIOLOGY OF DISEASE
- The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium
- (2015) Brian C. Shonesy et al. NEUROPHARMACOLOGY
- Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus
- (2015) Y. Li et al. NEUROSCIENCE
- Changes in Cannabinoid Receptors, Aquaporin 4 and Vimentin Expression after Traumatic Brain Injury in Adolescent Male Mice. Association with Edema and Neurological Deficit
- (2015) Ana Belen Lopez-Rodriguez et al. PLoS One
- Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms
- (2015) Paula Suárez-Pinilla et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease
- (2015) Neife Aparecida Guinaim Santos et al. TOXICOLOGY IN VITRO
- Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
- (2015) E Singer et al. Cell Death & Disease
- Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis
- (2015) Sven G Meuth et al. Expert Review of Neurotherapeutics
- Time-Dependent Protection of CB2 Receptor Agonist in Stroke
- (2015) Seong-Jin Yu et al. PLoS One
- Cannabis and Schizophrenia
- (2015) J. A. Pushpa-Rajah et al. SCHIZOPHRENIA BULLETIN
- Efficacy and safety of medical cannabinoids in older subjects: A systematic review
- (2014) G.A.H. van den Elsen et al. AGEING RESEARCH REVIEWS
- Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
- (2014) Salvador Sierra et al. Brain Structure & Function
- Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease
- (2014) Itay Lotan et al. CLINICAL NEUROPHARMACOLOGY
- Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93ATransgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
- (2014) Miguel Moreno-Martet et al. CNS Neuroscience & Therapeutics
- Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
- (2014) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Normal aging in rats and pathological aging in human Alzheimer’s disease decrease FAAH activity: Modulation by cannabinoid agonists
- (2014) A.C. Pascual et al. EXPERIMENTAL GERONTOLOGY
- CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
- (2014) János Haskó et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
- (2014) M. H. N. Chagas et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
- (2014) Gareth Pryce et al. Journal of Neuroimmune Pharmacology
- Neuroprotective Potential of Adenosine A2Aand Cannabinoid CB1Receptor Antagonists in an Animal Model of Parkinson Disease
- (2014) Silvia Cerri et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage
- (2014) Miriam Fishbein-Kaminietsky et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis
- (2014) Paula de Robles et al. NEURO-ONCOLOGY
- The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
- (2014) Diana Fernández-Suárez et al. NEUROBIOLOGY OF AGING
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury
- (2014) Flaubert Tchantchou et al. NEUROPHARMACOLOGY
- Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
- (2014) Sara Valdeolivas et al. Neurotherapeutics
- Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
- (2014) Hai-Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
- (2014) David Cheng et al. PSYCHOPHARMACOLOGY
- Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
- (2014) Valéria Almeida et al. SCHIZOPHRENIA RESEARCH
- Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
- (2014) Daniel J. Hermanson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Neurobehavioral, neuropathological and biochemical profiles in a novel mouse model of co-morbid post-traumatic stress disorder and mild traumatic brain injury
- (2014) Joseph O. Ojo et al. Frontiers in Behavioral Neuroscience
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies
- (2014) Guoqiang Xing et al. Frontiers in Neurology
- Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration
- (2014) Richard P Tobin et al. Acta Neuropathologica Communications
- Role of cannabinoid CB2receptor in the reinforcing actions of ethanol
- (2013) Antonio Ortega-Álvaro et al. ADDICTION BIOLOGY
- Cannabinoid Receptor 2 Activation
- (2013) Shilpa J. Buch AMERICAN JOURNAL OF PATHOLOGY
- Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier
- (2013) Slava Rom et al. AMERICAN JOURNAL OF PATHOLOGY
- Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS
- (2013) N Murataeva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Changes in CB1and CB2receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
- (2013) Carmen Rodríguez-Cueto et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
- (2013) Emelie Janefjord et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS
- (2013) Weimin Kong et al. CELLULAR IMMUNOLOGY
- CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice
- (2013) A. B. Lopez-Rodriguez et al. CEREBRAL CORTEX
- Biosynthetic Pathways of Bioactive N-Acylethanolamines in Brain
- (2013) Kazuhito Tsuboi et al. CNS & Neurological Disorders-Drug Targets
- Differential expression and functional role of cannabinoid genes in alcohol users
- (2013) Marisela Agudelo et al. DRUG AND ALCOHOL DEPENDENCE
- In vivo type 1 cannabinoid receptor availability in Alzheimer's disease
- (2013) Rawaha Ahmad et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Modulating the endocannabinoid system in human health and disease - successes and failures
- (2013) Pál Pacher et al. FEBS Journal
- Bilateral Changes of Cannabinoid Receptor Type 2 Protein and mRNA in the Dorsal Root Ganglia of a Rat Neuropathic Pain Model
- (2013) Ivana Hradilová Svíženská et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Cognitive Change in Newly-Diagnosed Patients with Parkinson's Disease: A 5-Year Follow-up Study
- (2013) Mark Broeders et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
- (2013) Daniel J Hermanson et al. NATURE NEUROSCIENCE
- Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina
- (2013) Bruno Cécyre et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing and Physical Effects of Nicotine
- (2013) Francisco Navarrete et al. NEUROPSYCHOPHARMACOLOGY
- Mechanism of platelet activation induced by endocannabinoids in blood and plasma
- (2013) S. Annette Brantl et al. PLATELETS
- Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
- (2013) Carolina Muguruza et al. SCHIZOPHRENIA RESEARCH
- Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance
- (2012) Sarah Dubreucq et al. BIOLOGICAL PSYCHIATRY
- Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
- (2012) Massimo Nabissi et al. CARCINOGENESIS
- The Endocannabinoid System and Schizophrenia: Integration of Evidence
- (2012) Erica Zamberletti et al. CURRENT PHARMACEUTICAL DESIGN
- Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
- (2012) Raquel Levin et al. CURRENT PHARMACEUTICAL DESIGN
- The therapeutic potential of the endocannabinoid system for Alzheimer's disease
- (2012) Tim Karl et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cannabinoid Receptors CB1and CB2Form Functional Heteromers in Brain
- (2012) Lucía Callén et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
- (2012) S. H. Ramirez et al. JOURNAL OF NEUROSCIENCE
- A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
- (2012) Peter S. Amenta et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Selective Inhibition of Alpha/Beta-Hydrolase Domain 6 Attenuates Neurodegeneration, Alleviates Blood Brain Barrier Breakdown, and Improves Functional Recovery in a Mouse Model of Traumatic Brain Injury
- (2012) Flaubert Tchantchou et al. JOURNAL OF NEUROTRAUMA
- Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model
- (2012) L. E. Goldstein et al. Science Translational Medicine
- A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease
- (2012) Justin R. Piro et al. Cell Reports
- Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease
- (2012) Rongqing Chen et al. Cell Reports
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Cognitive Impairment and Dementia in Parkinson’s Disease: Clinical Features, Diagnosis, and Management
- (2012) Joana Meireles et al. Frontiers in Neurology
- General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
- (2012) Olga Golubnitschaja et al. EPMA Journal
- Endocannabinoid system dysfunction in mood and related disorders
- (2011) C. H. Ashton et al. ACTA PSYCHIATRICA SCANDINAVICA
- Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage
- (2011) Fadi Assaf et al. BEHAVIOURAL BRAIN RESEARCH
- In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis
- (2011) K. Goffin et al. BRAIN
- Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease
- (2011) Jan Mulder et al. BRAIN
- Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates
- (2011) Noriko Suzuki et al. BRAIN RESEARCH
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
- (2011) C García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endocannabinoids and traumatic brain injury
- (2011) Esther Shohami et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice
- (2011) Francisco Navarrete et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
- (2011) María S García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids, endocannabinoids, and cancer
- (2011) Daniel J. Hermanson et al. CANCER AND METASTASIS REVIEWS
- Estradiol Decreases Cortical Reactive Astrogliosis after Brain Injury by a Mechanism Involving Cannabinoid Receptors
- (2011) A. B. Lopez Rodriguez et al. CEREBRAL CORTEX
- Role of Cannabinoids in Multiple Sclerosis
- (2011) John P. Zajicek et al. CNS DRUGS
- Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
- (2011) Y. C. Chung et al. JOURNAL OF IMMUNOLOGY
- CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
- (2011) Emmanuel S Onaivi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
- (2011) Zheng-Xiong Xi et al. NATURE NEUROSCIENCE
- Clinical diagnosis and management of amyotrophic lateral sclerosis
- (2011) Orla Hardiman et al. Nature Reviews Neurology
- Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
- (2011) Koen Van Laere et al. NEUROBIOLOGY OF AGING
- Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
- (2011) Victoria S Dalton et al. NEUROPSYCHOPHARMACOLOGY
- Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
- (2011) Antonio Ortega-Alvaro et al. NEUROPSYCHOPHARMACOLOGY
- Huntington's disease: a clinical review
- (2011) Raymund A.C. Roos Orphanet Journal of Rare Diseases
- Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
- (2011) T. Tsetsenis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia
- (2011) Beng-Choon Ho et al. SCHIZOPHRENIA RESEARCH
- Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
- (2011) D. K. Nomura et al. SCIENCE
- Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
- (2011) Juan G. Zarruk et al. STROKE
- Effects of endocannabinoid system modulation on cognitive and emotional behavior
- (2011) Claudio Zanettini Frontiers in Behavioral Neuroscience
- Acute management of acquired brain injury part II: An evidence-based review of pharmacological interventions
- (2010) Matthew J. Meyer et al. BRAIN INJURY
- 2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors
- (2010) Oliver P. Keown et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The endocannabinoid system as a target for the treatment of neurodegenerative disease
- (2010) Emma L Scotter et al. BRITISH JOURNAL OF PHARMACOLOGY
- Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
- (2010) MS García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner
- (2010) Massimo Nabissi et al. CARCINOGENESIS
- Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
- (2010) Patricia Reggio CURRENT MEDICINAL CHEMISTRY
- Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules
- (2010) Yan Zhao et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
- (2010) María S García-Gutiérrez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- (2010) Mohanraj Rajesh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo
- (2010) Gabriel M. Simon et al. Molecular BioSystems
- Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Homeostatic changes of the endocannabinoid system in Parkinson's disease
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
- (2010) Jason R Clapper et al. NATURE NEUROSCIENCE
- Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
- (2010) Victoria E. Johnson et al. NATURE REVIEWS NEUROSCIENCE
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
- (2010) Dean F. Wong et al. NEUROIMAGE
- The Maturation of GABAergic Transmission in Visual Cortex Requires Endocannabinoid-Mediated LTD of Inhibitory Inputs during a Critical Period
- (2010) Bin Jiang et al. NEURON
- Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
- (2010) Stephen M Eggan et al. NEUROPSYCHOPHARMACOLOGY
- IN VIVO PET IMAGING OF CEREBRAL TYPE 1 CANNABINOID RECEPTOR AVAILABILITY IN PATIENTS WITH SCHIZOPHRENIA
- (2010) Jenny Ceccarini et al. SCHIZOPHRENIA RESEARCH
- The Role of the Endogenous Cannabinoid System in Peripheral Analgesia
- (2010) Josee Guindon et al. Current Molecular Pharmacology
- Cannabis, Cannabinoids and Schizophrenia: Integration of the Evidence
- (2009) Martin Cohen et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Therapeutic Time Window of Cannabidiol Treatment on Delayed Ischemic Damage via High-Mobility Group Box1-Inhibiting Mechanism
- (2009) Kazuhide Hayakawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
- (2009) Javier Palazuelos et al. BRAIN
- Emerging strategies for exploiting cannabinoid receptor agonists as medicines
- (2009) Roger G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2009) David A. Price et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia
- (2009) Glenn Schwarcz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cannabinoid CB1 Receptor-Dependent Long-Term Depression in Autaptic Excitatory Neurons
- (2009) Ryan Kellogg et al. JOURNAL OF NEUROPHYSIOLOGY
- Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway
- (2009) M. T. Viscomi et al. JOURNAL OF NEUROSCIENCE
- Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
- (2009) S. G. Kinsey et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cognitive decline in Parkinson’s disease: A prospective longitudinal study
- (2009) DINO MUSLIMOVIĆ et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Self-modulation of neocortical pyramidal neurons by endocannabinoids
- (2009) Silvia Marinelli et al. NATURE NEUROSCIENCE
- Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease
- (2009) M.J. Dowie et al. NEUROSCIENCE
- Detection of behavioral alterations and learning deficits in mice lacking synaptophysin
- (2009) U. Schmitt et al. NEUROSCIENCE
- Endocannabinoid-Mediated Control of Synaptic Transmission
- (2009) Masanobu Kano et al. PHYSIOLOGICAL REVIEWS
- Role of cannabis and endocannabinoids in the genesis of schizophrenia
- (2009) Emilio Fernandez-Espejo et al. PSYCHOPHARMACOLOGY
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
- (2009) Leyre Urigüen et al. PSYCHOPHARMACOLOGY
- Pretreatment With Electroacupuncture Induces Rapid Tolerance to Focal Cerebral Ischemia Through Regulation of Endocannabinoid System
- (2009) Qiang Wang et al. STROKE
- Δ9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells
- (2008) Gil Galanti et al. ACTA ONCOLOGICA
- Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia
- (2008) Iván Chavarría-Siles et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- The Endocannabinoid System in Parkinsons Disease
- (2008) Massimiliano Di Filippo et al. CURRENT PHARMACEUTICAL DESIGN
- The Endocannabinoid System in Huntingtons Disease
- (2008) M. Pazos et al. CURRENT PHARMACEUTICAL DESIGN
- Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
- (2008) Cecilia Hillard CURRENT PHARMACEUTICAL DESIGN
- The Role of the Endocannabinoid System in Alzheimers Disease: Facts and Hypotheses
- (2008) Tiziana Bisogno et al. CURRENT PHARMACEUTICAL DESIGN
- Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson model
- (2008) Sanneke A.M. van Vliet et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia
- (2008) Daniela Vigano et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis
- (2008) M Di Filippo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons
- (2008) S. Marinelli et al. JOURNAL OF NEUROSCIENCE
- Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus
- (2008) A. Ludanyi et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury
- (2008) M. Zhang et al. NEUROSCIENCE
- Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia
- (2008) Christophe Mallet et al. PAIN
- Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
- (2008) Francisco J Alvarez et al. PEDIATRIC RESEARCH
- Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review
- (2008) I SVIZENSKA et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats
- (2008) Nico Wegener et al. PSYCHOPHARMACOLOGY
- The Impact of Substance Abuse on Mortality in Patients With Severe Traumatic Brain Injury
- (2008) Kristine OʼPhelan et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Prostamides (prostaglandin-ethanolamides) and their pharmacology
- (2007) D F Woodward et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
- (2007) E J Rahn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors
- (2007) G Pryce et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alzheimer's disease; taking the edge off with cannabinoids?
- (2007) V A Campbell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anhedonia and Social Adaptation Predict Substance Abuse Evolution in Dual Diagnosis Schizophrenia
- (2007) Stéphane Potvin et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started